Episode Details
Back to Episodes
MustGrow Biologics Expands U.S. Reach as Demand Outpaces Supply | MustGrow Biologics (TSXV: MRGO)
Description
MustGrow Biologics (TSXV: MRGO) continues to expand the commercial rollout of TerraSante across the United States while positioning itself to benefit from growing demand for biological crop protection solutions.
In this episode, listeners will hear COO Colin Bletsky discuss expanding state registrations, why demand has exceeded supply, the strategic importance of the company's Bayer partnership, and how global regulatory trends are creating opportunities for biological agriculture.
This episode covers:
- TerraSante's U.S. commercialization strategy
- Growing customer demand and production expansion
- Bayer's role in advancing commercialization
- Global regulatory shifts toward biological agriculture
- MustGrow's long-term growth strategy
Disclaimer:
This podcast is made in partnership with MustGrow Biologics. This podcast is for informational purposes only and should not be considered investment advice. Please do your own due diligence before making any investment decisions. For our full disclaimer, visit: https://stockhouse.com/legal/disclaimer
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.